Purchase 4-Aco-DMT
Discount program, second-order - 5% OFF, third order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy 4-Aco-DMT for sale
O-Acetylpsilocin (also known as psilocybin, 4-acetoxy-DMT, 4-AcO-DMT, or synthetic shrooms) is a semi-synthetic psychoactive drug that David Nichols has suggested to be a potentially useful alternative to psilocybin for pharmacological studies. However, some users report that O-acetylpsilocin's subjective effects differ from those of psilocybin and psilocin.
O-Acetylpsilocin (O-Acetylpsilocin) is a chemical never before seen in nature. O-Acetylpsilocin is known as an intermediary substance to psilocin, or "magic mushrooms."
O-Acetylpsilocin, also known as Psilacetin, is a relatively new synthetic psychedelic substance. It's one of the latest byproducts of the booming chemistry industry.
O-Acetylpsilocin is used for studying the role of serotonin in brain physiology.
O-acetylpsilocin is an organic compound with the chemical formula C14H17NO3. This colorless crystal is soluble in alcohol and soluble in water.
O-Acetylpsilocin is a semi-synthetic psychoactive drug suggested as a potential alternative to psilocybin for pharmacological studies.
O-acetylpsilocin or 4-Acetoxy-DMT is a promising alternative to psilocybin.
O-Acetylpsilocin, commonly known as "acetylpsilocin," is the acetylated form of psilocin - a close chemical relative (an isomer) of the hallucinogenic drug psilocybin. Acetylpsilocin can be ingested orally, or it can be snorted through the nose. It has a potency level similar to that of psilocybin but with a substantially shorter duration.
O-Acetylpsilocin (4-AcO-DMT) is a powerful chemical substance found in various plants but can also be created by humans.
O-Acetylpsilocin (also known as psilocybin, 4-acetoxy-DMT, 4-AcO-DMT, or synthetic shrooms)was first reported in 1970 by Albert Hofmann.
O-Acetylpsilocin is a psychedelic.
O-Acetylpsilocin (4-AcO-DMT or psilocybin) is a semi-synthetic psychoactive drug that David Nichols has suggested could be a potentially useful alternative to psilocybin for pharmacological studies, as they are both believed to be prodrugs of the corresponding phenethylamine, psilocin.
O-Acetylpsilocin (4-AcO-DMT or psilocybin) is a semi-synthetic psychoactive drug that David Nichols has suggested as a potentially useful alternative to psilocybin for pharmacological studies.
O-Acetylpsilocin (4-AcO-DMT or, more commonly known, psilocin) is a semi-synthetic psychedelic drug that David Nichols has suggested to be a potentially useful alternative to psilocybin for pharmacological studies.
O-Acetylpsilocin (4-AcO-DMT or psilocybin) is a psychedelic drug that David Nichols has suggested as a potentially useful alternative to psilocybin for pharmacological studies, as it is similar in structure to psilocybin.
O-Acetylpsilocin, also known as 4-acetoxy-N, N-dimethyltryptamine or psilocin, is a semi-synthetic psychedelic drug of the tryptamine class.
AcO-DMT (psilocin) is a semisynthetic psychedelic prodrug of the neurotransmitter serotonin (5-HT).
O-Acetylpsilocin (also known as psilocybin, 4-acetoxy-DMT, 4-AcO-DMT, or synthetic shrooms) is a semi-synthetic psychoactive drug that David Nichols has suggested to be a potentially useful alternative to psilocybin for pharmacological studies.
O-Acetylpsilocin (OAP) is a semi-synthetic psychedelic compound that has been suggested by David Nichols to be used as an alternative to psilocybin for pharmacological studies.
Then, O-Acetylpsilocin (4-AcO-DMT) is a psychonaut drug that David Nichols has suggested as a potentially useful alternative to psilocybin for scientific studies.
O-Acetylpsilocin (4-AcO-DMT) is a semi-synthetic psychedelic drug of the tryptamine class, which produces psilocin as a metabolite.
O-acetylpsilocin (also known as psilocybin, 4-Acetoxy-DMT, or synthetic shrooms) is the psilocybin molecule with the acetoxy group attached to the phosphoryl oxygen.
O-acetylpsilocin is structurally similar to psilocybin, differing only in substituting an acetyl group for the 4-oxygen atom on the indole ring.
O-Acetylpsilocin is a powerful hallucinogen as potent as psilocybin.
O-acetylpsilocin, also known as 4-AcO-DMT or 4-Acetoxy-DMT, is a psychoactive compound of the tryptamine class. It is similar in structure to psilocin (4-HO-DMT), the active metabolite of psilocybin.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics